Rare diseases
Investigational molecules
Locations
Slotsmarken 12, 1 Th, 2970, Denmark
Reponex Pharmaceuticals A/S is involved in clinical research on pouchitis in patients with ulcerative colitis after ileal pouch-anal anastomosis. Its studies focus on the inflammatory and microbial features of the condition, with attention to treatment strategies that address local disease activity in the intestinal pouch.
The sponsor’s work in this area centers on therapeutic interest in restoring balance within the pouch environment and improving management of chronic pouch inflammation.
Reponex Pharmaceuticals A/S runs clinical trials in conditions such as Peritonitis, Pouchitis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study on GM-CSF, Fosfomycin, and Metronidazole for Treating Pouchitis in Ulcerative Colitis Patients Post-Surgery
DenmarkStudy of intraperitoneal fosfomycin, metronidazole and molgramostim treatment in patients with multi-quadrant peritonitis during abdominal surgery
DenmarkStudy on Intraperitoneal Treatment with Fosfomycin, Metronidazole, and Molgramostim for Patients with Multi-Quadrant Peritonitis Undergoing Abdominal Surgery
DenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
